New lead compounds for Tuberculosis booster by structure-based drug discover with GOLD

被引：0
|
作者：
Pohl, E. [1 ]
Tatum, N. J. [1 ]
Coles, J. C. [2 ]
Willand, N. [3 ,4 ]
Baulard, A. R. [3 ,4 ]
机构：
[1] Univ Durham, Dept Chem, Durham DH1 3LE, England
[2] Cambridge Crystallog Data Ctr, 12 Union Rd, Cambridge CB2 1EZ, England
[3] Inst Pasteur, F-59019 Lille, France
[4] PRIM, F-59019 Lille, France
来源：
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS | 2017年 / 46卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P-779
引用
收藏
页码：S318 / S318
页数：1
相关论文
共 50 条
  • [1] New active leads for tuberculosis booster drugs by structure-based drug discovery
    Tatum, Natalie J.
    Liebeschuetz, John W.
    Cole, Jason C.
    Frita, Rosangela
    Herledan, Adrien
    Baulard, Alain R.
    Willand, Nicolas
    Pohl, Ehmke
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2017, 15 (48) : 10245 - 10255
  • [2] IN SEARCH OF NEW LEAD COMPOUNDS FOR TRYPANOSOMIASIS DRUG DESIGN - A PROTEIN STRUCTURE-BASED LINKED-FRAGMENT APPROACH
    VERLINDE, CLMJ
    RUDENKO, G
    HOL, WGJ
    JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (02) : 131 - 147
  • [3] Beyond the Virtual Screening Paradigm: Structure-Based Searching for New Lead Compounds
    Schlosser, Jochen
    Rarey, Matthias
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (04) : 800 - 809
  • [4] Structure-based approaches to drug discovery against tuberculosis
    Holton, Simon J.
    Weiss, Manfred S.
    Tucker, Paul A.
    Wilmanns, Matthias
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2007, 8 (04) : 365 - 375
  • [5] Strategies for structure-based drug design - Potential means to narrow the number of promising lead compounds
    Weiss, MD
    GENETIC ENGINEERING NEWS, 2002, 22 (07): : 16 - +
  • [6] Structure-Based Drug Design for Tuberculosis: Challenges Still Ahead
    Bruch, Eduardo M.
    Petrella, Stephanie
    Bellinzoni, Marco
    APPLIED SCIENCES-BASEL, 2020, 10 (12):
  • [7] New Targets for Structure-Based Drug Discovery
    Andrews, Steve
    Congreve, Miles
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2017, 17 (01) : 2 - 3
  • [8] Structure-based drug design identifies polythiophenes as antiprion compounds
    Herrmann, Uli S.
    Schuetz, Anne K.
    Shirani, Hamid
    Huang, Danzhi
    Saban, Dino
    Nuvolone, Mario
    Li, Bei
    Ballmer, Boris
    Aslund, Andreas K. O.
    Mason, Jeffrey J.
    Rushing, Elisabeth
    Budka, Herbert
    Nystrom, Sofie
    Hammarstrom, Per
    Boeckmann, Anja
    Caflisch, Amedeo
    Meier, Beat H.
    Nilsson, K. Peter R.
    Hornemann, Simone
    Aguzzi, Adriano
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (299)
  • [9] Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis
    Balasubramani, G. L.
    Rajput, Rinky
    Gupta, Manish
    Dahiya, Pradeep
    Thakur, Jitendra K.
    Bhatnagar, Rakesh
    Grover, Abhinav
    BIOCHEMICAL JOURNAL, 2020, 477 (21) : 4167 - 4190
  • [10] Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
    Kingdon, Alexander D. H.
    Alderwick, Luke J.
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 : 3708 - 3719
12345